COVID-19 showed us that we urgently need more transparency in reporting adverse vaccine effects and that compensation for ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

Vaccine skeptics have long-since leveraged the rapid roll out of mRNA vaccines to add fuel to heated arguments surrounding ...

COVID-19 infection, compared with influenza, is associated with increased myocarditis rates among adults in the United States.

Now the Johns Hopkins University surgeon and researcher has been nominated to lead the Food and Drug Administration. The ...

Researchers discovered that myocarditis varies based on its cause, with post-COVID-19 cases triggering a stronger immune response than vaccine-related inflammation. These findings may help refine ...

Heart inflammation, or myocarditis, differs depending on its cause. A collaborative study led by Dr. Henrike Maatz, a scientist in the Genetics and Genomics of Cardiovascular Diseases lab of Professor ...

The Maine CDC is excited to announce that we are modernizing our Tuberculosis (TB) reporting system. Currently, inactive TB (also known as Latent TB Infection or LTBI) cases and suspect and confirmed ...

Myocarditis Market Outlook 2025-2035: The 7 major myocarditis market reached a value of USD 1,438.2 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 2,391.5 Million by 2035, ...

Premium Quality Power IPO Day 2 Highlights: The subscription period for the Quality Power IPO is scheduled from Friday, February 14, to Tuesday, February 18. Quality Power IPO Day 2 Highlights ...